Breaking News Instant updates and real-time market news.

MYL

Mylan

$40.80

0.07 (0.17%)

14:20
04/23/18
04/23
14:20
04/23/18
14:20

Mylan layoffs will led to questions, says Wells Fargo

Wells Fargo analyst David Maris acknowledges press reports that Mylan is laying off approximately 500 employees, or approximately 15% of its employees in Morgantown, Virginia. Investors will have questions when Mylan reports Q1 results about the layoffs and what Mylan means about the need to make the Morgantown plant less complex, Maris tells investors in a research note. He keeps a Market Perform on Mylan shares.

  • 27

    Apr

  • 18

    May

  • 13

    Nov

MYL Mylan
$40.80

0.07 (0.17%)

04/19/18
WELS
04/19/18
NO CHANGE
WELS
Wells says bottom has not been reached in generics pricing
After Aceto (ACET) cited the continued intense competitive and pricing pressures in the generic industry when withdrawing its guidance last night, and Novartis (NVS) this morning reported that net sales at its generic unit Sandoz dropped 4% in the quarter, Wells Fargo analyst Davis Maris says he's not ready to call the bottom in generics pricing. Those that have are premature, Maris tells investors in a research note titled "Negative Read Throughs For Generics Continue." The Aceto and Sandoz pricing news shows the data continue to be negative for U.S. generic industry pricing, the analyst contends. He sees a negative read-through for companies with large U.S. commodity generic exposure, such as Teva (TEVA) and Mylan (MYL).
04/18/18
LEHM
04/18/18
NO CHANGE
Target $230
LEHM
Overweight
Barclays sees 'significant challenges' for Botox biosimilar
Barclays analyst Douglas Tsao says that while he'd probably stop short of calling it "mission impossible," he sees "significant challenges" in the development of a biosimilar to Allergan's (AGN) Botox. Following a deep dive into the key issues Mylan (MYL) will likely face in developing a biosimilar Botox, the analyst and concluded that it seems "technically difficult and faces a long road ahead." Even a best case scenario puts timing out to 2023, Tsao tells investors in a research note. The analyst has an Overweight rating on Allergan with a $230 price target.
04/12/18
04/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Incyte (INCY) upgraded to Buy from Neutral at UBS with analyst Carter Gould saying the stock offers an improved risk/reward profile after resetting lower on negative epacadostat Phase 3 data and removal of the drug from analyst models. 2. TechnipFMC (FTI) upgraded to Buy from Neutral at Goldman Sachs with analyst Waqar Syed saying while his 2018/2019 EBITDA estimates are little changed, his 2020 EBITDA estimates have been raised nearly 18% owing to expectations for higher inbound orders in 2019 for the Subsea and Onshore/Offshore segments. 3. Prologis (PLD) upgraded to Buy from Hold at Jefferies with analyst Jonathan Petersen saying he sees the company posting one of the strongest levels of internal growth among the blue-chip real estate investment trusts in 2018. 4. Mylan (MYL) upgraded to Outperform from Market Perform at Leerink with analyst Ami Fadia citing valuation disconnect given the diversified business and catalyst path. 5. Summit Hotel Properties (INN) upgraded to Buy from Underperform at BofA/Merrill with analyst Shaun Kelley citing relative valuation, its potential to outperform peers on the top-line in an accelerating RevPAR environment, and lower relative cost pressure given a lower proportion of labor costs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/12/18
JPMS
04/12/18
NO CHANGE
Target $53
JPMS
Overweight
Mylan shares remain 'highly inexpensive,' says JPMorgan
JPMorgan analyst Chris Schott says his positive longer term thesis is unchanged following Mylan's investor day. Commentary on the near-term pipeline remained upbeat and Mylan highlighted multiple long-term revenue drivers, Schott tells investors in a research note. He believes the company's "significant" generic Advair opportunity, as well as other potential near-term approvals, more than offset any downside risk from ongoing challenges in the U.S. generics market. The analyst thinks Mylan shares remain "highly inexpensive." Schott keeps an Overweight rating on the name with a $53 price target.

TODAY'S FREE FLY STORIES

ELTK

Eltek

$3.05

(0.00%)

08:35
12/11/18
12/11
08:35
12/11/18
08:35
Hot Stocks
Eltek receives not in compliance letter from NASDAQ »

Eltek announced that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPS

Cooper-Standard

$66.48

-0.67 (-1.00%)

, POL

PolyOne

$30.74

-0.24 (-0.77%)

08:34
12/11/18
12/11
08:34
12/11/18
08:34
Hot Stocks
Cooper-Standard licenses Fortrex material platform to PolyOne Corp. »

Cooper Standard (CPS) has…

CPS

Cooper-Standard

$66.48

-0.67 (-1.00%)

POL

PolyOne

$30.74

-0.24 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$2.20

0.08 (3.77%)

08:34
12/11/18
12/11
08:34
12/11/18
08:34
Hot Stocks
Cellectar Biosciences granted Japanese patent for CLR 131 »

Cellectar Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$1.35

(0.00%)

08:33
12/11/18
12/11
08:33
12/11/18
08:33
Conference/Events
Viveve Medical to hold a webinar »

Webinar entitled,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TRPX

Therapix Biosciences

$5.33

(0.00%)

08:33
12/11/18
12/11
08:33
12/11/18
08:33
Hot Stocks
Therapix Biosciences provided update regarding LOI with FSD »

Therapix Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESQ

Esquire Financial

$24.00

0.27 (1.14%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Hot Stocks
Esquire Financial names Eric Bader as COO, Michael Lacapria as CFO »

Esquire Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZO

Carrizo Oil & Gas

$14.61

-1.28 (-8.06%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Downgrade
Carrizo Oil & Gas rating change  »

Carrizo Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

WELL

Welltower

$73.07

-0.66 (-0.90%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Upgrade
Welltower rating change  »

Welltower upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$13.58

-0.535 (-3.79%)

, VSAT

ViaSat

$65.44

-0.01 (-0.02%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Conference/Events
Morgan Stanley to hold a summit »

Space Summit to be held…

MAXR

Maxar Technologies

$13.58

-0.535 (-3.79%)

VSAT

ViaSat

$65.44

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

ONCS

OncoSec

$0.87

0.0553 (6.79%)

08:31
12/11/18
12/11
08:31
12/11/18
08:31
Hot Stocks
OncoSec announces new data on treatment with TAVO »

OncoSec Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:31
12/11/18
12/11
08:31
12/11/18
08:31
Conference/Events
Jefferies to hold a summit »

Office & Industrial…

PWR

Quanta Services

$30.72

-0.6 (-1.92%)

08:31
12/11/18
12/11
08:31
12/11/18
08:31
Conference/Events
Quanta Services management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AGYS

Agilysys

$15.51

-0.08 (-0.51%)

, ALRM

Alarm.com

$49.99

-0.7 (-1.38%)

08:31
12/11/18
12/11
08:31
12/11/18
08:31
Conference/Events
Maxim to hold a conference »

Maxim Group TMT…

AGYS

Agilysys

$15.51

-0.08 (-0.51%)

ALRM

Alarm.com

$49.99

-0.7 (-1.38%)

ATNI

ATN International

$76.15

-1.62 (-2.08%)

BRQS

Borqs Technologies

$3.88

-0.02 (-0.51%)

CTRL

Control4

$20.01

0.24 (1.21%)

EBIX

Ebix

$47.91

0.74 (1.57%)

HYRE

HyreCar

$2.14

0.36 (20.22%)

MCLD

McLeodUSA

$0.00

(0.00%)

OSTK

Overstock.com

$18.89

1.52 (8.75%)

SMCI

Super Micro Computer

$0.00

(0.00%)

STMP

Stamps.com

$172.88

1.12 (0.65%)

TEUM

Pareteum

$1.69

-0.02 (-1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

UBER

Uber

$0.00

(0.00%)

08:30
12/11/18
12/11
08:30
12/11/18
08:30
Periodicals
Uber seeks to expand relationship with Transport for London, FT reports »

Uber has had discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCLR

Oclaro

$8.27

(0.00%)

08:30
12/11/18
12/11
08:30
12/11/18
08:30
Options
One option delisting on December 11th »

Option delistings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRMW

Primo Water

$13.73

0.16 (1.18%)

08:30
12/11/18
12/11
08:30
12/11/18
08:30
Conference/Events
Primo Water management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HT

Hersha Hospitality

$18.49

-0.27 (-1.44%)

08:28
12/11/18
12/11
08:28
12/11/18
08:28
Downgrade
Hersha Hospitality rating change  »

Hersha Hospitality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$55.95

-2.45 (-4.20%)

08:27
12/11/18
12/11
08:27
12/11/18
08:27
Periodicals
Chinese consumers boycott Canada Goose over Huawei, Globes Times reports »

Canada Goose is a target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBX

Unity Biotechnology

$14.27

0.27 (1.93%)

08:26
12/11/18
12/11
08:26
12/11/18
08:26
Conference/Events
Unity Biotechnology to hold an event on cellular senescence »

Experts discuss the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BCO

Brink's

$61.97

-0.13 (-0.21%)

08:26
12/11/18
12/11
08:26
12/11/18
08:26
Hot Stocks
Brink's enters $50M accelerates share repurchase »

Brink's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

CAMP

CalAmp

$17.02

-0.23 (-1.33%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Downgrade
CalAmp rating change  »

CalAmp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

DVMT

Dell Technologies

$104.13

0.12 (0.12%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
Dell Technologies to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 07

    Mar

AWK

American Water

$97.50

-0.22 (-0.23%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
American Water to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ENB

Enbridge

$31.40

-0.54 (-1.69%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
Enbridge to hold investor conference »

2018 Enbridge Day--Annual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CNNE

Cannae Holdings

$17.00

0.26 (1.55%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
Cannae Holdings participates in a conference call with Stephens »

President Bickett and EVP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.